Overcoming amplification-mediated resistance to sotorasib by dose re-escalation in KRAS G12C mutant NSCLC: a case report. Vitale A, Vita E, Stefani A, Cancellieri A, et al. Oncologist 2025;30:oyaf030.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Vitale A, Vita E, Stefani A, Cancellieri A, et al. Overcoming amplification-mediated resistance to sotorasib by dose re-escalation in KRAS G12C mutant NSCLC: a case report. Oncologist 2025;30:oyaf030.
PMID: 40110764